| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amgen Inc (AMGN) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AMGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.2K | $174.14M | - | |
| VP | 83.4K | $28.74M | - | |
| VP | 51.2K | $17.66M | - | |
| CFO | 50.7K | $17.48M | - | |
| VP | 42.8K | $14.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 22, 2020 | Sugar Ronald D | Director | Sale+OE | 1,000 | $233.35 | $233,350.00 | -6.4% | |
| Feb 6, 2020 | Piacquad David | SVP, Business Development | Sell | 9,264 | $229.93 | $2,130,078.93 | -18.9% | |
| Feb 6, 2020 | Williams R Sanders54 | Director | Sell | 425 | $233.72 | $99,331.00 | -7.9% | |
| Nov 25, 2019 | Meline David W | EVP &CFO | Sell | 8,737 | $234.36 | $2,047,603.32 | -15.0% | |
| Nov 22, 2019 | Graham Jonathan P | EVP, Gen. Counsel &Secy. | Sell | 9,000 | $230.54 | $2,074,836.60 | -17.4% | |
| Nov 6, 2019 | Williams R Sanders54 | Director | Sell | 425 | $215.45 | $91,566.25 | -7.3% | |
| Nov 6, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $215.45 | $430,900.00 | -12.2% | |
| Oct 2, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $193.58 | $387,160.00 | -12.2% | |
| Sep 4, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $206.70 | $413,400.00 | -12.2% | |
| Aug 30, 2019 | Patton Cynthia M | SVP &CCO | Sale+OE | 13,426 | $208.07 | $2,793,510.23 | -15.0% |